← Back to Patent Explorer
US4930516A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for detecting cancerous tissue using visible native luminescence

Assignee: Laser Diagnostic Instruments AS
•
Filing: 1988-04-25
•
Granted: 1990-06-05
•
Expires: 2008-04-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and apparatus for detecting the presence of cancerous tissue using visible luminescence. The tissue to be examined is excited with a beam of monochromatic light that causes the tissue to fluoresce over a spectrum of wavelengths. The intensity at which the excited tissue fluoresces can be measured either over a spectrum or at a predetermined number of preselected wavelengths. By determining the wavelength(s) at which maximum intensity(ies) are attained for the tissue in question and by comparing these peak wavelengths, either visually or electronically, to the peak wavelength(s) derived from a known non-cancerous tissue, or by comparing the spectrum of the excited tissue with the spectrum of a known noncancerous tissue one can determine the carcinomatoid status of the tissue in question. The invention is based on the discovery that the visible luminescence spectra for cancerous and non-cancerous tissue are substantially different and that the differences are such that visible luminescence from tissue can be used to detect the presence of cancer.

Inventors

  • 👤 Robert R. Alfano
  • 👤 Michele A. Alfano

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:46
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/0059; Y; Y10; Y10S; Y10S607/00; Y10S607/901

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 44 words
A method for determining if tissue is cancerous comprising: a. exciting a tissue to be examined with a beam of light, and b. comparing the visible native luminescence emitted from the tissue with the visible native luminescence emitted from tissue whose condition is known.
Claim 2
Independent Claim 44 words
A method for determining if tissue is cancerous comprising: a. exciting a tissue to be examined with a beam of light, and b. comparing the visible native luminescence emitted from the tissue with the visible native luminescence emitted from tissue whose condition is known.
Claim 3
Independent Claim 48 words
A method for determining if tissue is cancerous comprising: a. exciting a tissue to be examined with a beam of light. b. observing the visible native luminescence emitted from the tissue at least two wavelengths, and c. determining if the tissue is cancerous in accordance with said measurements.
Claim 4
Independent Claim 48 words
A method for determining if tissue is cancerous comprising: a. exciting a tissue to be examined with a beam of light. b. observing the visible native luminescence emitted from the tissue at least two wavelengths, and c. determining if the tissue is cancerous in accordance with said measurements.
Claim 5
Independent Claim 43 words
A method for detecting cancerous tissue comprising: a. exciting a tissue to be examined with a beam of light that is substantially monochromatic, and then b. comparing the resulting native luminescence spectrum with the native luminescence spectra for native normal and cancerous tissue.
Claim 6
Independent Claim 43 words
A method for detecting cancerous tissue comprising: a. exciting a tissue to be examined with a beam of light that is substantially monochromatic, and then b. comparing the resulting native luminescence spectrum with the native luminescence spectra for native normal and cancerous tissue.
Claim 7
Independent Claim 55 words
A method for detecting cancerous tissue comprising: a. exciting a tissue to be examined with a beam of light that is at least substantially monochromatic. b. measuring the intensity of the visible native luminescence emitted from the tissue at least two wavelengths, and c. determining if the tissue is cancerous in accordance with said measurements.
Claim 8
Independent Claim 55 words
A method for detecting cancerous tissue comprising: a. exciting a tissue to be examined with a beam of light that is at least substantially monochromatic. b. measuring the intensity of the visible native luminescence emitted from the tissue at least two wavelengths, and c. determining if the tissue is cancerous in accordance with said measurements.
Claim 9
Dependent Claim 41 words
The method of claim 4 and wherein determining if cancerous tissue is present comprises determining the ratios in intensities at at least two wavelengths and then comparing the ratios with the ratios of intensities at the same wavelengths for normal tissue.
Claim 10
Dependent Claim 33 words
The method of claim 4 and wherein determining if cancerous tissue is present includes producing a signal corresponding to the ratio between the intensities at least two wavelengths and then displaying said signals.
Claim 11
Dependent Claim 29 words
The method of claim 4 and wherein determining if cancerous tissue is present comprises producing a signal corresponding to the difference in the intensity at at least two wavelengths.
Claim 12
Dependent Claim 24 words
The method of claim 4 and wherein determining if cancerous tissue is present comprises producing a signal corresponding to the difference in spectral profiles.
Claim 13
Independent Claim 47 words
A method for detecting cancerous tissue comprising: a. exciting a tissue to be examined with a beam of monochromatic light. b. generating a luminescence spectrum native of light emitted by the tissue, and c. comparing the luminescent spectrum with a luminescent spectrum for a known normal tissue.
Claim 14
Independent Claim 47 words
A method for detecting cancerous tissue comprising: a. exciting a tissue to be examined with a beam of monochromatic light. b. generating a luminescence spectrum native of light emitted by the tissue, and c. comparing the luminescent spectrum with a luminescent spectrum for a known normal tissue.

References Cited (Backward Citations)

US3647299A Cited
US3789832A Cited
US4213462A Cited
US4170987A Cited
US4479499A Cited
US4569354A Cited
GB2125986A Cited
US4637400A Cited
US4718417A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-06-04 1993-12-04 1994-06-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-06-04 1997-12-04 1998-06-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-06-04 2001-12-04 2002-06-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag